Studying everything from potential medicine to the aromatic properties of popular beverages, about 120 undergraduates put project posters on display April 22 at the 30th Annual Spring Research Forum.
Repairogen, the newest startup company in the Kevin M. McGovern Family Center for Venture Development incubator, promises to repair sun-damaged skin - and someday possibly prevent skin cancer.
Cornell researchers have discovered that the cell’s protein-making machinery, called ribosomes, exists in a hybrid form to meet different needs encountered under normal and stressed conditions.
Human mothers’ experience of pain and the expression of distress occur today because human ancestors who cried for help survived in greater numbers, according a hypothesis by Cornell psychologist Barbara L. Finlay.
An international team of researchers has discovered a pair of genetic mutations that drive tumor growth in patients who have a deadly subtype of T-cell lymphoma. The findings could lead to new targeted therapies for this aggressive disease.
Weill Cornell Medical College investigators have invalidated a previously reported molecular finding on triple negative breast cancer that many hoped would lead to targeted treatments for the aggressive disease.
Fredrick Blaisdell '16 and Steven Ingram '16 have received 2015 Udall scholarships, for students who show potential for careers in environmental public policy, health care and tribal public policy.
Partial knee replacements are superior economically to total knee replacements in older adults, new research from Weill Cornell Medical College and Hospital for Special Surgery investigators suggests.
Cornell University will partner with the Democratic Republic of the Congo’s Eben-Ezer University of Minembwe to offer two virtual courses, one on peace building and another on African disease patterns.
